Promoter hypermethylation of Syndecan-2 (SDC2) and TFPI2 occurs early in the adenoma-carcinoma sequence and provides stable, highly sensitive targets for noninvasive molecular diagnostics in resource-limited settings. (Front Mol Biosci)
SDC2 and TFPI2 methylation biomarkers offer noninvasive early detection opportunity in Latin America
The CRC Digest